This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new booster shot of the Pfizer-BioNTech COVID-19 vaccine is now available for children aged 6 months to 4 years, in an effort to continue to curb the effects of COVID-19
The latest version of software tool MZmine, which aids analysis of mass spectrometry data, has been released. Using this third generation software, scientists can analyse large volumes of data from mass spectrometry, processing thousands of samples within minutes to hours. [the newest version can process] thousands of samples within minutes to hours.” It is the first tool with an entire data processing pipeline that integrates liquid chromatography (LC)-ion mobility spectrometry (IMS)-MS a
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. When Novartis acquired AveXis and its spinal muscular atroph.
New targeted drug revumenib facilitated complete response in around 40 percent of patients with acute leukaemia subtypes, according to data in a new pair of studies ( 1 ) and ( 2 ) published in Nature. The two genetic subtypes of acute leukaemia involved in this research are “driven by a rearrangement of the MLL1 gene or a mutation in the NPM1 gene.
Bill Miller, senior vice president of central retail operations, will serve as Rite Aid's acting head of retail operations, and Karen Staniforth, chief pharmacy officer, will oversee store pharmacy operations.
WASHINGTON — The Biden administration will fine drugmakers who hiked prices faster than the rate of inflation on 27 medications administered in physicians’ offices, the agency said Wednesday. Pfizer had the most drugs on the list of any manufacturer, with five. Seagen’s bladder cancer drug Padcev, which also garnered penalties, will likely soon be in Pfizer’s portfolio, too, after the pharma giant completes its $43 billion acquisition of the Washington state company.
Barilla is celebrating Mikaela Shiffrin’s 87th World Cup victory with a pasta pack that features the brand’s iconic blue box pasta recipe made into 8 and 7 shapes.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
It may seem like there’s an elderberry version of everything: These days, you see it in pies, teas, juice, alcoholic beverages, and dietary supplements. Although it may seem trendy now, people have been using elderberries as food and medicine for thousands of years. Elderberry originates from Europe, Northern Africa, and Western and Central Asia.
As hospitals and companies continue t o leverage artificial intelligence in medicine, researchers are also grappling with how to check the AI systems to protect patient safety. “Risk management is a tricky business,” said Gyorgy Simon, scientific co-director for the University of Minnesota’s clinical AI program. “Treatment models are changing, the population is changing.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT’s Matthew Herper struck an industry nerve when he wrote that the drug development industry is “not prepared for the next wave of biotech innovation.” His report ends on a somewhat dismal note: the industry is long on diagnosis (clinical development is too expensive) and short on cures.
More than 7,500 associates will volunteer at over 200 organizations, including Keep America Beautiful affiliates, parks, zoos, gardens and other nonprofits focused on environmental sustainability.
Danish pharmaceutical company Novo Nordisk has announced that it will cut its prices for insulin products by up to 75%, beginning in January 2024. The price of Novolog and Novolog Mix 70/30 will be cut by 75%, with Novolin and Levemir seeing a 65% reduction in price. Novo’s cuts will take effect around the same time that the American Rescue Plan will be introduced.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fluticasone is one of the most commonly used inhaled corticosteroids for the management of asthma and other respiratory conditions. I’ve encountered drug interactions frequently with fluticasone because it is metabolized by CYP3A4. I’ve seen this interaction flagged on many drug interaction programs. In this article, I’ll discuss the practical implications of dealing with inhaled fluticasone […] The post Inhaled Fluticasone and CYP3A4 Interactions appeared first on Med Ed
WASHINGTON — After years of struggling to regulate the drug middlemen that create pharmacy networks, the federal government could lean on states to rein them in — even, potentially, in Medicare. The Department of Justice has until next month to tell a federal appeals court where the administration stands on the issue. Insurers determine what drugs are covered, where their customers can obtain these drugs, and how much drug costs their customers must pay for.
Nanoparticle-based drug formulations are a promising option for drug delivery with numerous beneficial attributes. They have the potential to increase the bioavailability of drugs with low aqueous solubility, target specific cells or tissues, and release drugs in a controlled manner to reduce toxicity. Currently more than 50 nanoparticle therapies are approved for clinical use in the US and Europe.
After two years as host of the “First Opinion Podcast” and many more as the founding editor of STAT’s expansive, authoritative First Opinion platform, Pat Skerrett put down his editing pen and microphone to start a new chapter — retirement. Pat bade us farewell with a favorite quote from Maurice Sendak’s “Where the Wild Things Are”: “Let the wild rumpus start!
Prenatal leukotriene receptor antagonist use has been found to not increase the risk of adverse neuropsychiatric events in their children Prenatal leukotriene receptor antagonist use does not appear to significantly elevate the risk of developing neuropsychiatric events among their offspring according to the findings of a study by Taiwanese researchers.
Pholcodine containing medicines are being withdrawn in the UK by the MHRA after a review suggested the risks outweigh the benefits The opioid pholcodine, is approved for use in adults and children over 6 years of age for a dry or non-productive cough and is also present in some cough and cold remedies. The MHRA in the UK has said that pholcodine containing cough and cold medicines are being withdrawn from the UK market as a precaution following a review and will no longer be available from pharm
The Patient Assistance solutions ensure patients receive their medications, even if alternative funding is unavailable or they don’t qualify for need-based assistance.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content